RSS News Feeds
Day High: 8.65
Day Low: 7.58
4:00 PM ET Oct 2, 2015
Delayed at least 20 min., by eSignal.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.
Sep 8, 2015
Tetraphase Announces Top-Line Results From IGNITE2 Phase 3 Clinical Trial of Eravacycline in cUTI
Sep 3, 2015
FDA Grants QIDP Designation and Fast Track Status to TP-271